文献速递炎症性肠病

降低C反应蛋白阈值可改善急性溃疡性结肠炎的风险分层

Lowering the C-Reactive Protein (CRP) Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity-Matched Analysis.
PubMed 文献 · Aliment Pharmacol Ther · 2026-07-18

本研究分析了503例连续急性UC住院患者,发现145例(29%)不符合TWC的ASUC标准(归为NASUC),其主要表型为无全身毒性的排便频率≥6次/24小时(77%)。将CRP阈值降至≥12 mg/L可重新分类26%的NASUC为ASUC,并捕获43%(6/14)一年内需结肠切除术的患者;倾向匹配后ASUC与NASUC的结肠切除风险无显著差异。

要点

  • 住院NASUC患者并不良性,其结肠切除风险与匹配后的ASUC相当。
  • 将CRP阈值降至≥12 mg/L可改善对当前TWC漏诊的高危患者的识别。
  • NASUC主要表型为排便频率≥6次/24小时且无全身毒性(77%)。

核心结论

  • NASUC并非良性临床实体,匹配客观疾病严重度和治疗后,其结肠切除风险与ASUC住院患者相当。
  • 降低CRP阈值(≥12 mg/L)可改善对当前标准TWC漏诊的高危患者的识别。

研究设计与样本

  • 回顾性分析2015-2024年单中心503例连续急性UC住院患者。
  • 不符合TWC的ASUC标准者归类为NASUC,采用倾向评分匹配比较ASUC与NASUC的结肠切除风险。

主要发现

  • 145例(29%)急性UC住院患者不符合TWC的ASUC标准。
  • NASUC主要表型为排便频率≥6次/24小时且无全身毒性(77%)。
  • 将CRP阈值降至≥12 mg/L可重新分类26%的NASUC患者为ASUC,并捕获43%(6/14)一年内需结肠切除术的患者。
  • 倾向匹配后ASUC与NASUC的结肠切除率在30天(9% vs. 5%,p=0.367)、90天(11% vs. 5%,p=0.158)和1年(18% vs. 13%,p=0.479)均无显著差异,至末次随访亦无差异(p=0.77)。

关键数值与推荐

  • 降低的CRP阈值为≥12 mg/L。
  • TWC阳性ASUC与NASUC的结肠切除率在30天、90天、1年及末次随访均无显著差异(p值分别为0.367、0.158、0.479、0.77)。

临床怎么用

  • 对住院UC患者应考虑使用降低的CRP阈值(≥12 mg/L)识别高危NASUC患者。
  • NASUC患者需积极管理,不应因其未达ASUC标准而低估结肠切除风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Real-world data demonstrate that patients hospitalised with non-acute severe UC (NASUC) experience intravenous corticosteroid (IVCS) failure rates approaching those of ASUC, yet no dedicated management guidelines exist. AIMS: We aimed to determine whether inpatient medical therapy and colectomy risk differ between TWC-positive ASUC, compared to hospitalised patients who did not meet TWC (NASUC), and evaluate if a reduced CRP threshold (≥ 12 mg/L) improves case capture of high-risk patients. METHODS: We analysed 503 consecutive acute UC admissions to a tertiary IBD centre (2015-2024). Patients not meeting TWC for ASUC were classified as NASUC. Propensity score matching (PSM) compared colectomy risk between ASUC and NASUC after adjustment for gender, endoscopic severity, disease extent and therapy on admission. RESULTS: A total of 145 (29%) acute UC admissions did not meet TWC for ASUC. The predominant NASUC phenotype was stool frequency ≥ 6/24 h without systemic toxicity (77%). Lowering the CRP threshold to ≥ 12 mg/L would have reclassified 26% of NASUC patients as ASUC, capturing 43% (6/14) of patients who required colectomy within 1-year. After PSM, there was no significant difference in colectomy between ASUC and NASUC at 30-days (9% vs. 5%, p = 0.367), 90-days (11% vs. 5%, p = 0.158) or 1-year (18% vs. 13%, p = 0.479) and until last follow-up (p = 0.77). CONCLUSION: NASUC is not a benign clinical entity. Colectomy risk were comparable between ASUC and NASUC inpatients when matched for objective disease severity and treatment exposure. A reduced CRP threshold (≥ 12 mg/L) improves identification of high-risk patients currently missed by the standard TWC.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Etchegaray A, Goetz N, Hanigan K, et al. Lowering the C-Reactive Protein (CRP) Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity-Matched Analysis. Aliment Pharmacol Ther. 2026. PMID: 42470242. doi:10.1111/apt.70825

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。